Ultrasound image-guided therapy enhances antitumor effect of cisplatin

Journal of Medical Ultrasonics

Volumn 41, Issue 1, 2014, Pages 11-21

  Sasaki, Noboru ^a   Kudo, Nobuki ^b   Nakamura, Kensuke ^a   Lim, Sue Yee ^a   Murakami, Masahiro ^a   Kumara, W R Bandula ^a   Tamura, Yu ^a   Ohta, Hiroshi ^a   Yamasaki, Masahiro ^a   Takiguchi, Mitsuyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Diagnostic ultrasound; Image guided drug delivery; Microbubble

Indexed keywords

CISPLATIN; PERFLUBUTANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL COUNT; CELL INTERACTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MICROBUBBLE; MOUSE; NONHUMAN; PETECHIA; THYROID CARCINOMA; TUMOR GROWTH; ULTRASOUND IMAGE GUIDED DRUG DELIVERY; ULTRASOUND SCANNER;

EID: 84893637319     PISSN: 13464523     EISSN: 16132254     Source Type: Journal    
DOI: 10.1007/s10396-013-0475-y     Document Type: Article

References (46)

1. Sleijfer D, Meijer S, Mulder NH. Cisplatin: a review of clinical applications and renal toxicity. Pharm Weekbl [Sci]. 1985;7:237-44.
2. Voke EE. Induction chemotherapy for head and neck cancer: recent data. Oncologist. 2010;15:3-7.
3. O'Dwyer PJ, Stevenson JP, Johnson SW. Clinical pharmacokinetics and administration of established platinum drugs. Drugs. 2000;59:19-27.
4. Giaccone G. Clinical perspectives on platinum resistance. Drugs. 2000;59:9-17.
5. Gately DP, Howell SB. Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer. 1983;67:1171-6.
6. Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265-79.
7. Testori A, Tosti G, Martinoli C, et al. Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach. Dermatol Ther. 2010;23:651-61.
8. Stathopoulos GP, Antoniou D, Dimitroulis J, et al. Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial. Ann Oncol. 2010;21:2227-32.
9. Plummer R, Wilson RH, Calvert H, et al. A phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumors. Br J Cancer. 2011;104:593-8.
10. Sonoda S, Tachibana K, Uchino E, et al. Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization. Cancer Biol Ther. 2007;6:1282-9.
11. Iwanaga K, Tominaga K, Yamamoto K, et al. Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther. 2007;14:354-63.
12. Watanabe Y, Aoi A, Horie S, et al. Low-intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin. Cancer Sci. 2008;99:2525-31.
13. Xing W, Gang WZ, Yong Z, et al. Treatment of xenografted ovarian carcinoma using paclitaxel-loaded ultrasound microbubbles. Acad Radiol. 2008;15:1574-9.
14. Kang J, Wu X, Wang Z, et al. Antitumor effect of docetaxel-loaded lipid microbubbles combined with ultrasound-targeted microbubbles activation on VX2 rabbit liver tumors. J Ultrasound Med. 2010;29:61-70.
15. Zhao YZ, Lu CT, Zhou ZC, et al. Enhancing chemotherapeutic drug inhibition on tumor growth by ultrasound: an in vivo experiment. J Drug Target. 2011;19:154-60.
16. Matsuo M, Yamaguchi K, Feril LB, et al. Synergistic inhibition of malignant melanoma proliferation by melphalan combined with ultrasound and microbubbles. Ultrason Sonochem. 2011;18:1218-24.
17. Sorace AG, Warram JM, Umphrey H, et al. Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer. J Drug Target. 2012;20:43-54.
18. Lin CY, Tseng HC, Shiu HR, et al. Ultrasound sonication with microbubbles disrupts blood vessels and enhances tumor treatments of anticancer nanodrug. Int J Nanomed. 2012;7:2143-52.
19. van Wamel A, Kooiman K, Harteveld M, et al. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release. 2006;112:149-55.
20. Juffermans LJM, van Dijk A, Jongenelen CAM, et al. Ultrasound and microbubble-induced intra- and intercellular bioeffects in primary endothelial cells. Ultrasound Med Biol. 2009;35:1917-27.
21. Tachibana K, Uchida T, Ogawa K, et al. Induction of cell-membrane porosity by ultrasound. Lancet. 1999;353:1409.
22. Kudo N, Okada K, Yamamoto K. Sonoporation by single-shot pulsed ultrasound with microbubbles adjacent to cells. Biophys J. 2009;96:4866-76.
23. Eisenbrey JR, Soulen MC, Wheatley MA. Delivery of encapsulated doxorubicin by ultrasound-mediated size reduction of drug-loaded polymer contrast agents. IEEE Trans Biomed Eng. 2007;57:24-8.
24. Tinkov S, Coester C, Serba S, et al. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in vivo characterization. J Control Release. 2010;148:368-72.
25. Price RJ, Skyba DM, Kaul S, et al. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation. 1998;98:1264-7.
26. Miller DL, Quddus J. Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice. Proc Natl Acad Sci USA. 2000;97:10179-84.
27. Miller DL, Quddus J. Lysis and sonoporation of epidermoid and phagocytic monolayer cells by diagnostic ultrasound activation of contrast agent gas bodies. Ultrasound Med Biol. 2001;27:1107-13.
28. Sasaki N, Kudo N, Nakamura K, et al. Activation of microbubbles by short-pulsed ultrasound enhances the cytotoxic effect of cis- diamminedichloroplatinum (II) in a canine thyroid adenocarcinoma cell line in vitro. Ultrasound Med Biol. 2012;38:109-18.
29. Hobbs SK, Monsky WL, Yuan F, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA. 1998;95:4607-12.
30. Hashizume H, Baluk P, Morikawa S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol. 2000;156:1363-80.
31. Kindberg GM, Tolleshaug T, Roos N, et al. Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres. Cell Tissue Res. 2003;312:49-54.
32. Sontum PC, Østensen J, Dyrstad K, et al. Acoustic properties of NC100100 and their relation with the microbubble size distribution. Invest Radiol. 1999;34:268-75.
33. Lamb H. Hydrodynamics. 6th ed. New York: Dover Publications; 1932.
34. Postema M, van Wamel A, Lancée CT, et al. Ultrasound-induced encapsulated microbubble phenomena. Ultrasound Med Biol. 2004;30:827-40.
35. Chomas JE, Dayton PA, May D, et al. Threshold of fragmentation for ultrasonic contrast agents. J Biom Opt. 2001;6:141-50.
36. Kinoshita M, Hynynen K. Key factors that affect sonoporation efficiency in in vitro settings: the importance of standing wave in sonoporation. Biochem Biophys Res Commun. 2007;359:860-5.
37. Gervais DA, Arellano RS. Percutaneous tumor ablation for hepatocellular carcinoma. Am J Roentgenol. 2011;197:789-94.
38. Sipos JA. Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid. 2009;19:1363-72.
39. Plante MK, Folsom JB, Zvara P. Prostatic tissue ablation by injection: a literature review. J Urol. 2004;172:20-6.
40. Gullo JJ, Litterst CL, Maguire PJ, et al. Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion. Cancer Chemother Pharmacol. 1980;5:21-6.
41. Stewart DJ, Benjamin RS, Luna M, et al. Human tissue distribution of platinum after cis-diamminedichloroplatinum. Cancer Chemother Pharmacol. 1982;10:51-4.
42. Leunig M, Yuan F, Menger MD, et al. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LSI74T in SCID mice. Cancer Res. 1992;52:6553-60.
43. Song J, Klibanov AL, Hossack JA, et al. Acoustic attenuation by contrast agent microbubbles in superficial tissue markedly diminishes petechiae bioeffects in deep tissue. Invest Radiol. 2008;43:322-9.
44. Leighton TG. The acoustic bubble. London: Academic Press; 1994. p. 312-41.
45. Caskey CF, Stieger SM, Qin S, et al. Direct observations of ultrasound microbubble contrast agent interaction with the microvessel wall. J Acoust Soc Am. 2007;122:1191-200.
46. Juffermans LJM, Dijkmans PA, Musters RJP, et al. Transient permeabilization of cell membranes by ultrasound-exposed microbubbles is related to formation of hydrogen peroxide. Am J Physiol Heart Circ Physiol. 2006;291:1595-601.